Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2019 09:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Welcomes New Executive Management Team

– Appointment of Current Director Michael Cavanaugh as Interim Chief Executive Officer –– Promotion of Current Controller and Counsel Richard McKilligan to Chief Financial Officer – LOS ANGELES, May ...
April 25, 2019 12:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors

LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of...
January 24, 2019 15:56 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board

LOS ANGELES, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid...
December 03, 2018 08:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma to Present at the 11th Annual LD Micro Main Event

LOS ANGELES, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug...
November 21, 2018 07:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination

Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
October 23, 2018 07:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Receives $8.5 Million Common Stock Financing

Financing to support company at least into 2020 and for the initiation of multiple Phase 2 clinical trials LOS ANGELES, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
October 03, 2018 07:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Announces Neural Repair Treatment Patent Filings

LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
September 13, 2018 06:30 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles

LOS ANGELES, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
August 21, 2018 06:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma THC Prodrug VBX-100 Demonstrates Positive Safety Results

LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
June 20, 2018 08:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program

LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...